Whole-body bioluminescence imaging of T-cell response in PDAC models

Front Immunol. 2023 Jul 11:14:1207533. doi: 10.3389/fimmu.2023.1207533. eCollection 2023.

Abstract

Introduction: The location of T-cells during tumor progression and treatment provides crucial information in predicting the response in vivo.

Methods: Here, we investigated, using our bioluminescent, dual color, T-cell reporter mouse, termed TbiLuc, T-cell location and function during murine PDAC tumor growth and checkpoint blockade treatment with anti-PD-1 and anti-CTLA-4. Using this model, we could visualize T-cell location and function in the tumor and the surrounding tumor microenvironment longitudinally. We used murine PDAC clones that formed in vivo tumors with either high T-cell infiltration (immunologically 'hot') or low T-cell infiltration (immunologically 'cold').

Results: Differences in total T-cell bioluminescence could be seen between the 'hot' and 'cold' tumors in the TbiLuc mice. During checkpoint blockade treatment we could see in the tumor-draining lymph nodes an increase in bioluminescence on day 7 after treatment.

Conclusions: In the current work, we showed that the TbiLuc mice can be used to monitor T-cell location and function during tumor growth and treatment.

Keywords: PDAC - pancreatic ductal adenocarcinoma; T-cell activation; bioluminescence imaging (BLI); immune checkpoint inhibitors (ICI); tumor microenvironment (TME); tumor-draining lymph nodes (TDLN).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes
  • Immunologic Tests
  • Mice
  • Neoplasms*
  • Tumor Microenvironment

Grants and funding

We acknowledge the funding received from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 777682 (CANCER) and No 813834 (pHioniC).